variants of unknown significance
Under a three-year deal, Illumina has licensed access to Tempus' multimodal data platform, which includes DNA and RNA data, clinical data, pathology slides, and radiology scans.
Researchers described the process they took to adapt their methodology for improved BRCA variant classification through ClinGen in a new study this week.
Constantiam Biosciences Nabs $2.05M Phase II SBIR Grant From NHGRI
The company will use the award to further develop its analytic platforms for the functional analysis and reclassification of variants of uncertain significance.
Breast Cancer Patients With VUS Generally Not Overtreated, Real-World Data Analysis Suggests
Premium
A study drawing on germline genetic testing and claims data showed at ASCO that patients with VUS are, for the most part, managed like they have negative results.
Labs, Doctors Still Grapple With Patient Recontact Despite Streamlined Variant Reclassification
Premium
Although leading labs have coalesced around the value of protocols for making sure updated variant calls get to patients, strategies still vary and practical challenges remain.